Get started
Author

Bingchen Han

Breast cancer lung metastasis: Molecular biology and therapeutic implications
2018 · Liting Jin, Bingchen Han, et al. · Cancer Biology & Therapy · 295
Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells
2015 · Ying Qu, Bingchen Han, et al. · PLoS ONE · 285
PDF
FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer
2015 · Bingchen Han, Ying Qu, et al. · Cell Reports · 149
PDF
Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids
2017 · Ying Qu, Bingchen Han, et al. · Stem Cell Reports · 80
FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer
2017 · Bingchen Han, Bo Zhou, et al. · Oncogene · 77
Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay
2015 · Tor W. Jensen, Tania Ray, et al. · JNCI Journal of the National Cancer Institute · 58
Characterization of primary human mammary epithelial cells isolated and propagated by conditional reprogrammed cell culture
2017 · Liting Jin, Ying Qu, et al. · Oncotarget · 44
PDF
FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer
2014 · Yanli Jin, Bingchen Han, et al. · Annals of Surgical Oncology · 40
Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer
2017 · Stacey Chung, Yanli Jin, et al. · Cell Communication and Signaling · 38
PDF
Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCs
2016 · Ying Qu, Bo Zhou, et al. · Scientific Reports · 32
PDF
A chemokine regulatory loop induces cholesterol synthesis in lung-colonizing triple-negative breast cancer cells to fuel metastatic growth
2021 · Bingchen Han, Felix Alonso-Valenteen, et al. · Molecular Therapy · 30
PDF
FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort
2016 · Jeff Johnson, Michael Choi, et al. · Oncotarget · 30
PDF
Multiple myeloma: Combination therapy of BET proteolysis targeting chimeric molecule with CDK9 inhibitor
2020 · Su-Lin Lim, Liang Xu, et al. · PLoS ONE · 18
PDF
Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics
2017 · Jessica D. Sims, Jan Michael Taguiam, et al. · Journal of Controlled Release · 15
PDF
Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment
2021 · Bowen Gao, Jiongyu Chen, et al. · Scientific Reports · 14
PDF
FOXC1-induced Gli2 activation: A non-canonical pathway contributing to stemness and anti-Hedgehog resistance in basal-like breast cancer
2016 · Bingchen Han, Ying Qu, et al. · Molecular & Cellular Oncology · 12
PDF
Inhibition of lobuloalveolar development by FOXC1 overexpression in the mouse mammary gland
2017 · Bowen Gao, Ying Qu, et al. · Scientific Reports · 7
PDF
Biology and Treatment of Basal-Like Breast Cancer
2013 · Bingchen Han, William Audeh, et al. · Humana Press eBooks · 4
TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity
2022 · Qizhi Liu, Stacey Chung, et al. · International Journal of Biological Sciences · 3
PDF
Kuwanon A from Morus alba L. Alleviates H2O2-Induced Oxidative Damage in HaCaT Keratinocytes by Inhibiting Ferroptosis and Enhancing Antioxidant Capacity
2026 · Yan Liu, Hening Fu, et al. · Antioxidants
Abstract A59: Assessment of conditional reprogramming to generate 2D and 3D primary human mammary cell culture models
2018 · Stacey Chung, Liting Jin, et al. · Molecular Cancer Research
Additional file 1: Figure S1. of Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer
2017 · Chung, Stacey, Yanli Jin, et al. · Figshare
Abstract P3-12-13: Radiation enhancement with cysteine coated platinum nanoparticles
2016 · S Wagner, Y Yue, et al. · Cancer Research
Abstract 1906: FOXC1 regulates cancer stem cells properties via inducing SMO-independent Gli activation and confers anti-Hedgehog drug resistance in basal-like breast cancer
2014 · Bingchen Han, Yanli Jin, et al. · Cancer Research
The basal phenotype as a clinically relevant indicator of trastuzumab resistance in HER2+ breast cancer.
2014 · Michael Phillip Choi, Alice P. Chung, et al. · Journal of Clinical Oncology
Works count: 26
Citation count: 1,230
H-index: 14
I10-index: 16
Year
Topic
Type